Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Explore

Analyst Notes

Stocks – Q : Quality | V : Valuation | PT : Price Trend
Funds – P : Performance | Q : Quality

Top Pharma Companies in India by Market Cap

BSE Sensex 76913.50
582.86 (-0.75%)

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Biocon Ltd.	Q V PT	58,280 Mid Cap	359.55 (-0.76%)	7935.88	2.17	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Park Medi World Ltd.	Q V PT	9,945 Small Cap	230.25 (-2.10%)	1415.1	11.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Wockhardt Ltd.	Q V+ PT	22,661 Small Cap	1,394.60 (0.13%)	1028.76	4.89	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	989 Small Cap	125.40 (5.38%)	645.46	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Fortis Healthcare Ltd.	Q V+ PT	69,709 Mid Cap	923.35 (-1.20%)	432.5	7.67	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Healthcare Global Enterprises Ltd.	Q V+ PT	8,548 Small Cap	572.55 (0.58%)	366.34	5.29	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Senores Pharmaceuticals Ltd.	Q V+ PT	4,139 Small Cap	898.70 (-0.16%)	300.62	5.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Nephrocare Health Services Ltd.	Q V+ PT	5,316 Small Cap	529.75 (-0.19%)	155.56	5.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Viyash Scientific Ltd.	Q V PT	8,919 Small Cap	204.15 (-1.52%)	117.91	10.07	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Onesource Specialty Pharma Ltd.	Q V PT	19,939 Small Cap	1,739.20 (-1.25%)	115.64	3.41	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Dr. Agarwals Health Care Ltd.	Q V PT	14,084 Small Cap	444.35 (0.62%)	111.04	7.09	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Aster DM Healthcare Ltd.	Q V+ PT	36,341 Small Cap	701.40 (0.28%)	110.83	7.88	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Neuland Laboratories Ltd.	Q V+ PT	19,243 Small Cap	14,998.70 (2.36%)	105.42	11.38	14.13	64.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Astrazeneca Pharma India Ltd.	Q V+ PT	20,543 Small Cap	8,217.20 (-1.95%)	104.3	25.2	15.59	20.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Rubicon Research Ltd.	Q V+ PT	16,019 Small Cap	970.30 (-0.20%)	95.81	12.41	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Krishna Institute of Medical Sciences Ltd	Q V PT	26,651 Small Cap	666.05 (0.11%)	92.35	11.27	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Cohance Lifesciences Ltd.	Q V+ PT	18,476 Small Cap	482.95 (3.22%)	88.75	4.69	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Laxmi Dental Ltd.	Q V PT	1,094 Small Cap	199 (-3.40%)	87.75	4.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Anthem Biosciences Ltd.	Q V PT	42,676 Mid Cap	759.75 (-2.06%)	86.08	14.69	23.81	40.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Gujarat Themis Biosyn Ltd.	Q V+ PT	3,964 Small Cap	363.75 (-3.22%)	85.7	14.79	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	7,894 Small Cap	819.30 (1.92%)	82.79	4.85	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,09,840 Large Cap	7,639.20 (-0.84%)	76.73	11.42	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Orchid Pharma Ltd.	Q V PT	3,188 Small Cap	628.50 (3.01%)	72.9	2.31	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Laurus Labs Ltd.	Q V+ PT	59,336 Mid Cap	1,099.10 (-0.60%)	70.78	11.8	14.42	4.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Acutaas Chemicals Ltd.	Q V+ PT	21,258 Small Cap	2,596.55 (3.84%)	70.12	13.4	32.80	16.82	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Divis Laboratories Ltd.	Q V PT	1,72,697 Large Cap	6,505.35 (-0.45%)	69.98	10.85	11.65	10.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	CORONA Remedies Ltd.	Q V+ PT	10,550 Small Cap	1,725 (2.12%)	69.31	14.75	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Max Healthcare Institute Ltd.	Q V PT	96,663 Mid Cap	993.20 (-1.24%)	68.96	9.45	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	8,616 Small Cap	547.40 (0.78%)	68.92	3.56	12.22	23.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Sai Life Sciences Ltd.	Q V+ PT	22,695 Small Cap	1,070.40 (1.45%)	68.02	9.32	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,297.45	13.59%
Syngene Internation.	467.90	8.30%
Guj. Kidney & Super	125.40	5.38%
Kopran	164.70	5.14%
Aarti Pharmalabs	744.25	4.91%

Company Name	CMP	Price Change(%)
3B Blackbio Dx	1,206.60	-4.77%
Lincoln Pharma	645.40	-4.19%
Sun Pharma Adv. Res	142.85	-3.71%
Laxmi Denta	199	-3.40%
Guj. Themis Biosyn	363.75	-3.22%

News about Top Pharma Companies in India

May, 2026

Max Healthcare Institute informs about allotment of equity shares

Max Healthcare Institute has informed that Nomination & Remuneration Committee (‘NRC’) of the Company on May 1, 2026, at 6.56 pm (IST), has approved the allotment of 51,287 equity shares having face value of ?10 each, fully paid-up, to eligible employees, consequent to the exercise of vested stock options in accordance with Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequent to the above allotment, the paid-up equity share capital of the Company stands increased from 973,19,25,020 to 973,24,37,890. In terms of regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the requisite details of equity shares allotted as above are enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Laurus Labs informs about press release

Laurus Labs has informed that it enclosed copies of the newspaper advertisement pertaining to Financial Results of the Company for the quarter and year ended March 31, 2026. The advertisements were published in Business Standard (English) and Prajasakti (Telugu) on May 01, 2026.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Aster DM Healthcare informs about earnings call

Aster DM Healthcare has informed that the Earnings Call of the Company for the quarter and year ended March 31, 2026, was held on May 01, 2026, and the Video/Audio Recording with respect to Earnings Call is available on the website of the Company at https://www.asterdmhealthcare.in/investors/financial-information/audio-video-recordings-earningsquarterly-calls.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Aster DM Healthcare - Quaterly Results

The revenue for the March 2026 quarter is pegged at Rs. 6551.00 millions, about 14.16% up against Rs. 5738.60 millions recorded during the year-ago period.The Company to register a -55.04% fall in the net profit for the quarter ended March 2026.The company reported a good operating profit of 1789.20 millions compared to 1500.30 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	6551.00	5738.60	14.16	26157.00	23204.80	12.72	26157.00	23204.80	12.72
Other Income	405.50	351.30	15.43	1550.30	57386.70	-97.30	1550.30	57386.70	-97.30
PBIDT	1789.20	1500.30	19.26	7054.10	61951.90	-88.61	7054.10	61951.90	-88.61
Interest	209.80	232.50	-9.76	872.70	855.70	1.99	872.70	855.70	1.99
PBDT	802.10	1003.60	-20.08	5282.20	64327.70	-91.79	5282.20	64327.70	-91.79
Depreciation	375.70	377.60	-0.50	1540.20	1445.20	6.57	1540.20	1445.20	6.57
PBT	426.40	626.00	-31.88	3742.00	62882.50	-94.05	3742.00	62882.50	-94.05
TAX	151.80	15.30	892.16	1063.80	792.80	34.18	1063.80	792.80	34.18
Deferred Tax	-47.50	-104.70	-54.63	-179.90	44.60	-503.36	-179.90	44.60	-503.36
PAT	274.60	610.70	-55.04	2678.20	62089.70	-95.69	2678.20	62089.70	-95.69
Equity	5181.30	4995.20	3.73	5181.30	4995.20	3.73	5181.30	4995.20	3.73
PBIDTM(%)	27.31	26.14	4.47	26.97	266.98	-89.90	26.97	266.98	-89.90

May, 2026

Acutaas Chemicals - Quaterly Results

The sales surged to Rs. 4217.72 millions, up 38.67% for the March 2026 quarter as against Rs. 3041.61 millions during the corresponding quarter previous year.The Net Profit of the company vaulted to 118.10% to Rs. 1370.71 millions from Rs. 628.48 millions in the previous quarter.Operating Profit saw a handsome growth to 1957.63 millions from 897.52 millions in the quarter ended March 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	4217.72	3041.61	38.67	13237.92	9898.35	33.74	13237.92	9898.35	33.74
Other Income	145.46	56.94	155.46	458.78	183.36	150.21	458.78	183.36	150.21
PBIDT	1957.63	897.52	118.12	5288.83	2434.78	117.22	5288.83	2434.78	117.22
Interest	10.72	3.83	179.90	30.77	58.57	-47.46	30.77	58.57	-47.46
PBDT	1946.91	893.69	117.85	5258.06	2376.21	121.28	5258.06	2376.21	121.28
Depreciation	88.30	65.56	34.69	330.32	240.45	37.38	330.32	240.45	37.38
PBT	1858.61	828.13	124.43	4927.74	2135.76	130.73	4927.74	2135.76	130.73
TAX	487.90	199.65	144.38	1265.99	540.29	134.32	1265.99	540.29	134.32
Deferred Tax	17.36	47.36	-63.34	111.09	70.58	57.40	111.09	70.58	57.40
PAT	1370.71	628.48	118.10	3661.75	1595.47	129.51	3661.75	1595.47	129.51
Equity	409.36	409.34	0.00	409.36	409.34	0.00	409.36	409.34	0.00
PBIDTM(%)	46.41	29.51	57.29	39.95	24.60	62.42	39.95	24.60	62.42

May, 2026

Laurus Labs - Quaterly Results

The revenue slipped marginally during the March 2026 quarter. A decline of about Rs. 15803.00 millions was observed as compared to Rs. 16500.10 millions during the corresponding quarter last year.Net profit declined -23.86% to Rs. 1917.90 millions from Rs. 2519.00 millions.The company reported a degrowth in operating Profit to 3884.50 millions from 4669.90 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	15803.00	16500.10	-4.22	60890.70	52169.80	16.72	60890.70	52169.80	16.72
Other Income	130.90	721.60	-81.86	774.30	1004.70	-22.93	774.30	1004.70	-22.93
PBIDT	3884.50	4669.90	-16.82	15156.90	10448.00	45.07	15156.90	10448.00	45.07
Interest	339.10	486.00	-30.23	1429.60	1822.00	-21.54	1429.60	1822.00	-21.54
PBDT	3545.40	4183.90	-15.26	13727.30	8626.00	59.14	13727.30	8626.00	59.14
Depreciation	951.70	881.90	7.91	3786.40	3587.90	5.53	3786.40	3587.90	5.53
PBT	2593.70	3302.00	-21.45	9940.90	5038.10	97.31	9940.90	5038.10	97.31
TAX	675.80	783.00	-13.69	2536.10	1234.20	105.49	2536.10	1234.20	105.49
Deferred Tax	-9.20	-37.70	-75.60	-315.10	-304.20	3.58	-315.10	-304.20	3.58
PAT	1917.90	2519.00	-23.86	7404.80	3803.90	94.66	7404.80	3803.90	94.66
Equity	1079.70	1078.50	0.11	1079.70	1078.50	0.11	1079.70	1078.50	0.11
PBIDTM(%)	24.58	28.30	-13.15	24.89	20.03	24.29	24.89	20.03	24.29

Rank	Company	Market Capitalization 2026 (INR crores)
1	Biocon Ltd.	58,280 Crore
2	Park Medi World Ltd.	9,945 Crore
3	Wockhardt Ltd.	22,661 Crore
4	Gujarat Kidney And Super Speciality Ltd.	989 Crore
5	Fortis Healthcare Ltd.	69,709 Crore
6	Healthcare Global Enterprises Ltd.	8,548 Crore
7	Senores Pharmaceuticals Ltd.	4,139 Crore
8	Nephrocare Health Services Ltd.	5,316 Crore
9	Viyash Scientific Ltd.	8,919 Crore
10	Onesource Specialty Pharma Ltd.	19,939 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,431	54,039	35.46	12.32	24.79	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,192	1,41,859	62.44	15.62	35.30	26.68
Ajanta Pharma Ltd. (S)	Very Good	2,825	35,289	34.78	7.69	23.80	24.45
Lupin Ltd. (M)	Somewhat Good	2,304	1,05,320	22.67	5.06	13.52	20.83
Zydus Lifesciences Ltd. (M)	Very Good	892	89,721	18.17	3.42	11.35	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
No Yearly Gainers for this list.				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,048	32,884	45.21	8.43	28.55	17.81
Mankind Pharma Ltd. (M)	Very Good	2,247	92,744	54.44	5.81	32.80	14.65
Laurus Labs Ltd. (M)	Very Good	1,099	59,336	66.76	11.20	33.62	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,323	1,10,421	19.83	2.97	11.91	13.26
Ajanta Pharma Ltd. (S)	Very Good	2,825	35,289	34.78	7.69	23.80	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	892	89,721	18.17	3.42	11.35	30.57
Cipla Ltd. (L)	Very Good	1,310	1,05,811	23.27	3.15	14.04	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,808	4,33,848	39.75	5.34	21.73	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,323	1,10,421	19.83	2.97	11.91	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,048	32,884	45.21	8.43	28.55	19.45

About MoneyWorks4Me

*Color code for outperformance consistency

*Number is average 3 year rolling returns

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Max Healthcare Institute informs about allotment of equity shares

Laurus Labs informs about press release

Aster DM Healthcare informs about earnings call

Aster DM Healthcare - Quaterly Results

Acutaas Chemicals - Quaterly Results

Laurus Labs - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Max Healthcare Institute informs about allotment of equity shares

Laurus Labs informs about press release

Aster DM Healthcare informs about earnings call

Aster DM Healthcare - Quaterly Results

Acutaas Chemicals - Quaterly Results

Laurus Labs - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.